May 13, 2020 / 10:18 PM / in 14 days

BRIEF-Arvinas Announces Updated Phase 1 Data Demonstrating Clinical Activity Of Protac

May 13 (Reuters) - Arvinas Inc:

* ARVINAS ANNOUNCES UPDATED PHASE 1 DATA DEMONSTRATING CLINICAL ACTIVITY OF PROTAC® PROTEIN DEGRADER ARV-110 IN PATIENTS WITH REFRACTORY PROSTATE CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below